{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T00:42:51Z","timestamp":1768005771041,"version":"3.49.0"},"reference-count":61,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2020,4,24]],"date-time":"2020-04-24T00:00:00Z","timestamp":1587686400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>The renin-angiotensin system (RAS) plays a main role in regulating blood pressure and electrolyte and liquid balance. Previous evidence suggests that RAS may represent an important target for the treatment of lung pathologies, especially for acute respiratory distress syndrome and chronic fibrotic disease. The scientific community has recently focused its attention on angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor 1 (AT1R) inhibitors and their possible benefit\/harms for patients infected by Coronavirus disease (COVID-19) who experience pneumonia, but there are still some doubts about the effects of these drugs in this setting.<\/jats:p>","DOI":"10.3390\/ijms21083003","type":"journal-article","created":{"date-parts":[[2020,4,24]],"date-time":"2020-04-24T11:42:14Z","timestamp":1587728534000},"page":"3003","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":78,"title":["COVID-19 and RAS: Unravelling an Unclear Relationship"],"prefix":"10.3390","volume":"21","author":[{"given":"Damiano","family":"D\u2019Ardes","sequence":"first","affiliation":[{"name":"Clinica Medica Institute, European Center of Excellence on Atherosclerosis, Hypertension and Dyslipidemia, \u201cG. D\u2019Annunzio\u201d University of Chieti-Pescara, 66100 Chieti, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Boccatonda","sequence":"additional","affiliation":[{"name":"Clinica Medica Institute, European Center of Excellence on Atherosclerosis, Hypertension and Dyslipidemia, \u201cG. D\u2019Annunzio\u201d University of Chieti-Pescara, 66100 Chieti, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilaria","family":"Rossi","sequence":"additional","affiliation":[{"name":"Clinica Medica Institute, European Center of Excellence on Atherosclerosis, Hypertension and Dyslipidemia, \u201cG. D\u2019Annunzio\u201d University of Chieti-Pescara, 66100 Chieti, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7225-0891","authenticated-orcid":false,"given":"Maria Teresa","family":"Guagnano","sequence":"additional","affiliation":[{"name":"Clinica Medica Institute, European Center of Excellence on Atherosclerosis, Hypertension and Dyslipidemia, \u201cG. D\u2019Annunzio\u201d University of Chieti-Pescara, 66100 Chieti, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Santilli","sequence":"additional","affiliation":[{"name":"Clinica Medica Institute, European Center of Excellence on Atherosclerosis, Hypertension and Dyslipidemia, \u201cG. D\u2019Annunzio\u201d University of Chieti-Pescara, 66100 Chieti, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Cipollone","sequence":"additional","affiliation":[{"name":"Clinica Medica Institute, European Center of Excellence on Atherosclerosis, Hypertension and Dyslipidemia, \u201cG. D\u2019Annunzio\u201d University of Chieti-Pescara, 66100 Chieti, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5213-7768","authenticated-orcid":false,"given":"Marco","family":"Bucci","sequence":"additional","affiliation":[{"name":"Clinica Medica Institute, European Center of Excellence on Atherosclerosis, Hypertension and Dyslipidemia, \u201cG. D\u2019Annunzio\u201d University of Chieti-Pescara, 66100 Chieti, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2020,4,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"H137","DOI":"10.1152\/ajpheart.00618.2015","article-title":"Biochemical Evaluation of the Renin-Angiotensin System: The Good, Bad, and Absolute?","volume":"310","author":"Chappell","year":"2016","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.coph.2017.12.002","article-title":"Targeting the renin\u2013angiotensin system as novel therapeutic strategy for pulmonary diseases","volume":"40","author":"Tan","year":"2018","journal-title":"Curr. Opin. Pharmacol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1253\/circj.CJ-12-1544","article-title":"Multiple functions of angiotensin-converting enzyme 2 and its relevance in cardiovascular diseases","volume":"77","author":"Kuba","year":"2013","journal-title":"Circ. J."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.micinf.2013.08.003","article-title":"ACE2\u2014From the renin-angiotensin system to gut microbiota and malnutrition","volume":"15","author":"Perlot","year":"2013","journal-title":"Microbes Infect."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.pharmthera.2010.06.003","article-title":"Trilogy of ACE2: A peptidase in the renin-angiotensin system, a SARS receptor, and a partner for amino acid transporters","volume":"128","author":"Kuba","year":"2010","journal-title":"Pharmacol. Ther."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nature03712","article-title":"Angiotensin-converting enzyme 2 protects from severe acute lung failure","volume":"436","author":"Imai","year":"2005","journal-title":"Nature"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"134","DOI":"10.4172\/2576-1471.1000134","article-title":"Angiotensin-(1\u20137) and the Regulation of Anti-Fibrotic Signaling Pathways","volume":"2","author":"Chappell","year":"2017","journal-title":"J. Cell Signal"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.tem.2008.01.003","article-title":"Angiotensin AT2 receptors: Control of renal sodium excretion and blood pressure","volume":"19","author":"Carey","year":"2008","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.pharmthera.2008.08.009","article-title":"AT2 receptors: Functional relevance in cardiovascular disease","volume":"120","author":"Jones","year":"2008","journal-title":"Pharmacol. Ther."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1152\/physrev.00023.2016","article-title":"The ACE2\/Angiotensin-(1\u20137)\/Mas axis of the renin-angiotensin system: Focus on Angiotensin-(1\u20137)","volume":"98","author":"Santos","year":"2018","journal-title":"Physiol. Rev."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1530\/JOE-12-0341","article-title":"Angiotensin-converting enzyme 2, angiotensin-(1\u20137) and Mas: New players of the renin-angiotensin system","volume":"216","author":"Santos","year":"2013","journal-title":"J. Endocrinol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/nature00786","article-title":"Angiotensin-converting enzyme 2 is an essential regulator of heart function","volume":"417","author":"Crackower","year":"2020","journal-title":"Nature"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1172\/JCI16980","article-title":"Altered blood pressure responses and normal cardiac phenotype in ACE2-null mice","volume":"116","author":"Gurley","year":"2006","journal-title":"J. Clin. Investig."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1161\/HYPERTENSIONAHA.108.114322","article-title":"Transgenic angiotensin-converting enzyme 2 overexpression in vessels of SHRSP rats reduces blood pressure and improves endothelial function","volume":"52","author":"Rentzsch","year":"2008","journal-title":"Hypertension"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1161\/HYPERTENSIONAHA.107.100693","article-title":"Cardiac overexpression of angiotensin converting enzyme 2 protects the heart from ischemia-induced pathophysiology","volume":"51","author":"Grobe","year":"2008","journal-title":"Hypertension"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1161\/01.HYP.0000205833.89478.5b","article-title":"Deletion of angiotensin-converting enzyme 2 accelerates pressure overload-induced cardiac dysfunction by increasing local angiotensin II","volume":"47","author":"Yamamoto","year":"2006","journal-title":"Hypertension"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1291\/hypres.31.1953","article-title":"Candesartan ameliorates cardiac dysfunction observed in angiotensin-converting enzyme 2-deficient mice","volume":"31","author":"Nakamura","year":"2008","journal-title":"Hypertens. Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1161\/01.HYP.38.3.665","article-title":"Angiotensin-(1\u20137): Cardioprotective effect in myocardial ischemia\/reperfusion","volume":"38","author":"Ferreira","year":"2001","journal-title":"Hypertension"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1161\/HYPERTENSIONAHA.108.122333","article-title":"Onset of experimental severe cardiac fibrosis is mediated by overexpression of Angiotensin-converting enzyme 2","volume":"53","author":"Masson","year":"2009","journal-title":"Hypertension"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/S0022-2828(03)00177-9","article-title":"Heart block, ventricular tachycardia, and sudden death in ACE2 transgenic mice with downregulated connexins","volume":"35","author":"Donoghue","year":"2003","journal-title":"J. Mol. Cell Cardiol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/SHK.0000000000000633","article-title":"Pulmonary Angiotensin-Converting Enzyme 2 (ACE2) and Inflammatory Lung Disease","volume":"46","author":"Jia","year":"2016","journal-title":"Shock"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s40635-015-0044-3","article-title":"Angiotensin-(1\u20137) improves oxygenation, while reducing cellular infiltrate and fibrosis in experimental Acute Respiratory Distress Syndrome","volume":"3","author":"Zambelli","year":"2015","journal-title":"Intensive Care Med. Exp."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e334","DOI":"10.1097\/CCM.0b013e31828a6688","article-title":"Angiotensin-(1\u20137) protects from experimental acute lung injury","volume":"41","author":"Klein","year":"2013","journal-title":"Crit. Care Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.acvd.2012.02.010","article-title":"Three key proteases\u2014Angiotensin-I-converting enzyme (ACE), ACE2 and renin\u2014Within and beyond the renin-angiotensin system","volume":"105","author":"Guang","year":"2012","journal-title":"Arch. Cardiovasc. Dis."},{"key":"ref_25","first-page":"H1186","article-title":"Role of angiotensin-converting enzyme and angiotensin II in development of hypoxic pulmonary hypertension","volume":"269","author":"Morrell","year":"1995","journal-title":"Am. J. Physiol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"L156","DOI":"10.1152\/ajplung.00313.2002","article-title":"Angiotensin II and the fibroproliferative response to acute lung injury","volume":"286","author":"Marshall","year":"2004","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1186\/s13054-017-1882-z","article-title":"Recombinant human ACE2: Acing out angiotensin II in ARDS therapy","volume":"21","author":"Zhang","year":"2017","journal-title":"Crit. Care"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/path.2987","article-title":"Acute respiratory distress syndrome leads to reduced ratio of ACE\/ACE2 activities and is prevented by angiotensin-(1\u20137) or an angiotensin II receptor antagonist","volume":"225","author":"Lutter","year":"2011","journal-title":"J. Pathol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1164\/rccm.2108086","article-title":"Angiotensin converting enzyme insertion\/deletion polymorphism is associated with susceptibility and outcome in acute respiratory distress syndrome","volume":"166","author":"Marshall","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1124\/jpet.102.037382","article-title":"Nonpeptide antagonists of AT1 receptor for angiotensin II delay the onset of acute respiratory distress syndrome","volume":"303","author":"Raiden","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1056\/NEJMra032498","article-title":"The Severe Acute Respiratory Syndrome","volume":"349","author":"Peiris","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/nature02145","article-title":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus","volume":"426","author":"Li","year":"2003","journal-title":"Nature"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/nm1267","article-title":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury","volume":"11","author":"Kuba","year":"2005","journal-title":"Nat. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1126\/science.1116480","article-title":"Structural biology: Structure of SARS coronavirus spike receptor-binding domain complexed with receptor","volume":"309","author":"Li","year":"2005","journal-title":"Science"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"7988","DOI":"10.1073\/pnas.0409465102","article-title":"Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry","volume":"102","author":"Hofmann","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1186\/s13054-017-1823-x","article-title":"A pilot clinical trial of recombinant human angiotensin-converting enzyme 2 in acute respiratory distress syndrome","volume":"21","author":"Khan","year":"2017","journal-title":"Crit. Care"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"3594","DOI":"10.1038\/ncomms4594","article-title":"Angiotensin-converting enzyme 2 protects from lethal avian influenza A H5N1 infections","volume":"5","author":"Zou","year":"2014","journal-title":"Nat. Commun."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1021\/acs.jmedchem.9b01780","article-title":"The Other Angiotensin II Receptor: AT 2 R as a Therapeutic Target","volume":"63","year":"2020","journal-title":"J. Med. Chem."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"L341","DOI":"10.1152\/ajplung.00360.2012","article-title":"Agonists of MAS oncogene and angiotensin II type 2 receptors attenuate cardiopulmonary disease in rats with neonatal hyperoxia-induced lung injury","volume":"305","author":"Wagenaar","year":"2013","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.2353\/ajpath.2010.090565","article-title":"Ventilator-induced inflammatory response in lipopolysaccharide-exposed rat lung is mediated by angiotensin-converting enzyme","volume":"176","author":"Lutter","year":"2010","journal-title":"Am. J. Pathol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/SHK.0000000000000302","article-title":"Angiotensin-converting enzyme inhibition attenuates lipopolysaccharide-induced lung injury by regulating the balance between angiotensin-converting enzyme and angiotensin-converting enzyme 2 and inhibiting mitogen-activated protein kinase activation","volume":"43","author":"Li","year":"2015","journal-title":"Shock"},{"key":"ref_42","first-page":"E005","article-title":"Advances in the research of cytokine storm mechanism induced by Corona Virus Disease 2019 and the corresponding immunotherapies","volume":"36","author":"Chen","year":"2020","journal-title":"Zhonghua Shao Shang Za Zhi"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1080\/22221751.2020.1746200","article-title":"Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension","volume":"9","author":"Meng","year":"2020","journal-title":"Emerg. Microbes Infect."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/path.1570","article-title":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis","volume":"203","author":"Hamming","year":"2004","journal-title":"J. Pathol."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Qian, K., Deng, Y., Tai, Y., Peng, J., Peng, H., and Jiang, L. (2020). Clinical Characteristics of 2019 Novel Infected Coronavirus Pneumonia: A Systemic Review and Meta-analysis. medRxiv.","DOI":"10.1101\/2020.02.14.20021535"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Li, L.Q., Huang, T., Wang, Y.Q., Wang, Z.-P., Liang, Y., Huang, T.-B., Xhang, H.-Y., Sun, W., and Wang, Y. (2020). 2019 Novel Coronavirus Patients\u2019 Clinical Characteristics, Discharge Rate and Fatality Rate of Meta-Analysis. J. Med. Virol., 92.","DOI":"10.1002\/jmv.25757"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1016\/j.jacc.2018.01.058","article-title":"Angiotensin-Converting Enzyme Inhibitors in Hypertension: To Use or Not to Use?","volume":"71","author":"Messerli","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_49","first-page":"E014","article-title":"Inhibitors of RAS Might Be a Good Choice for the Therapy of COVID-19 Pneumonia","volume":"43","author":"Sun","year":"2020","journal-title":"Zhonghua Jie He He Hu Xi Za Zhi"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Gurwitz, D. (2020). Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics. Drug Dev. Res.","DOI":"10.1002\/ddr.21656"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1161\/01.HYP.0000124667.34652.1a","article-title":"Upregulation of Angiotensin-Converting Enzyme 2 after Myocardial Infarction by Blockade of Angiotensin II Receptors","volume":"43","author":"Ishiyama","year":"2004","journal-title":"Hypertension"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1111\/jcmm.12573","article-title":"Perinatally administered losartan augments renal ACE2 expression but not cardiac or renal Mas receptor in spontaneously hypertensive rats","volume":"19","author":"Klimas","year":"2015","journal-title":"J. Cell Mol. Med."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Komukai, K., Mochizuki, S., and Yoshimura, M. (2010). Gender and the renin-angiotensin-aldosterone system. Fundam. Clin. Pharmacol.","DOI":"10.1111\/j.1472-8206.2010.00854.x"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1161\/ATVBAHA.112.248559","article-title":"Angiotensin converting enzyme 2 contributes to sex differences in the development of obesity hypertension in C57BL\/6 mice","volume":"32","author":"Gupte","year":"2012","journal-title":"Arter. Thromb. Vasc. Biol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1177\/1535370217718808","article-title":"Protective regulation of the ACE2\/ACE gene expression by estrogen in human atrial tissue from elderly men","volume":"242","author":"Bukowska","year":"2017","journal-title":"Exp. Biol. Med."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13293-019-0260-8","article-title":"Adipocyte deficiency of ACE2 increases systolic blood pressures of obese female C57BL\/6 mice","volume":"10","author":"Shoemaker","year":"2019","journal-title":"Biol. Sex Differ."},{"key":"ref_57","first-page":"191","article-title":"Individual variation of the SARS-CoV2 receptor ACE2 gene expression and regulation","volume":"3","author":"Chen","year":"2020","journal-title":"Preprints"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Zheng, Y.-Y., Ma, Y.-T., Zhang, J.-Y., and Xie, X. (2020). COVID-19 and the cardiovascular system. Nat. Rev. Cardiol.","DOI":"10.1038\/s41569-020-0360-5"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study","volume":"6736","author":"Zhou","year":"2020","journal-title":"Lancet"},{"key":"ref_61","unstructured":"(2020). 61. American College of Cardiology. COVID-19 Clinical Guidance For the Cardiovascular Care Team. J. Am. Coll. Cardiol., 1, 1\u20134."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/21\/8\/3003\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T14:09:12Z","timestamp":1760364552000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/21\/8\/3003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,24]]},"references-count":61,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2020,4]]}},"alternative-id":["ijms21083003"],"URL":"https:\/\/doi.org\/10.3390\/ijms21083003","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,24]]}}}